On November 5, 2021, WIPO Standard ST.26 was approved. This Standard defines the nucleotide and amino acid sequence disclosures in a patent application required to be included in a sequence listing, the manner in which those disclosures are to be represented, and the Document Type Definition (DTD) for a sequence listing in XML (Extensible Markup Language), being established July 1, 2022 as the date of generalized transition to the Standard ST.26.
Change in the Format of Patent Sequence Listing
Back to All Thought Leadership